Table 3.

Changes in EORTC STO-22 Scores

EORTC-STO 22	Baseline	7 day	3 mo	6 mo	p-value*	p-value†	p-value‡	p-value§
Body image	8.61±18.15	10.28±19.86	8.48±17.63	5.67±14.99	<0.001	0.0272	0.83	0.0052
Dysphagia	6.38±11.68	6.85±12.51	4.03±7.61	3.45±6.56	<0.001	0.2608	<0.001	<0.001
Pain	11.05±13.68	17.63±16.70	9.74±11.13	8.43±11.26	<0.001	<0.001	0.0513	0.0001
Reflux	10.32±13.94	8.78±14.19	7.01±11.05	6.21±11.59	<0.001	0.0182	<0.001	<0.001
Eating	5.04±9.51	7.05±12.72	3.42±8.53	2.77±7.44	<0.001	<0.001	0.0007	<0.001
Anxiety	21.14±20.34	25.96±18.36	20.38±15.77	17.92±15.14	<0.001	<0.001	0.725	0.0007
Dry mouth	17.58±23.27	17.97±22.73	16.09±21.27	14.70±20.69	<0.001	0.7601	0.2532	0.0158
Taste	4.73±13.26	5.78±15.77	3.16±11.06	1.99±9.11	<0.001	0.1566	0.0137	<0.001
Hair loss	34.77±29.33	30.87±24.31	29.30±21.72	29.73±23.30	<0.001	0.0873	0.029	0.1201

Data are presented as mean±SD.

EORTC STO-22, European Organization for Research and Treatment of Cancer gastric cancer-specific questionnaire.

^*p-value for the time effect using the generalized estimating equation (GEE) method;

^†p-value for comparison between screening and 7 days using the GEE method;

^‡p-value for comparison between screening and 3 months using the GEE method;

^§p-value for comparison between screening and 6 months using the GEE method.